Acelyrin, Inc. (SLRN) Misses Q3 EPS by 39c
Acelyrin, Inc. (NASDAQ: SLRN) reported Q3 EPS of ($0.87), $0.39 worse than the analyst estimate of ($0.48).
For earnings history and earnings-related data on Acelyrin, Inc. (SLRN) click here.
Acelyrin, Inc. (NASDAQ: SLRN) reported Q3 EPS of ($0.87), $0.39 worse than the analyst estimate of ($0.48).
For earnings history and earnings-related data on Acelyrin, Inc. (SLRN) click here.